CERRITOS, Calif.--(BUSINESS WIRE)--KabaFusion, a leading provider of specialty acute and chronic home infusion therapies, today announced it has acquired the home infusion assets of Lincare, a ...

New information about how to monitor medications given at home has been provided by the results of new research. Many autoimmune neuromuscular disorders, such as Myasthenia Gravis, myositis, and CIDP, ...

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a national specialty pharmacy benefit manager (SPBM TM) serving commercial, Medicare and Medicaid segments, announces the launch of its Intravenous ...

In the United States, there are approximately 250,000 people diagnosed with primary immunodeficiency disease (PIDD), and thousands more go undetected. PIDD occurs in patients born with an immune ...

US-based Memorial Hermann Health System has partnered with KabaFusion to offer its home infusion therapy services for individuals with chronic conditions. This collaboration also aims to provide the ...

DALLAS, January 13, 2025--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) ...

Data presented at biennial ESID meeting reveal pharmacoeconomic benefits of switching from IVIG to SCIg in primary immunodeficiency FLORENCE, Italy, Oct. 4, 2012 /CNW/ - Analysis using a new economic ...

'Bubble Boy' bill to create home treatment program awaits Obama's signature. Dec. 27, 2012, — -- If there's one thing Jenny Gardner is afraid of, it's hospitals. She has a primary ...

Connie Sullivan, president and CEO of the National Home Infusion Association (NHIA), discusses why at-home infusion is beneficial to patients and why so many patients reported feeling satisfied with ...

NEW YORK (Reuters Health) - Intravenous immunoglobulin (IVIg) may offer some relief for patients with sensorimotor neuropathy or nonataxic sensory neuropathy associated with primary Sjögren's syndrome ...